These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1600696)
1. Fatal bleeding in a patient with a non-specific PT and APTT inhibitor. Krikler SH; Carter CJ; Chonn A; Levitt D; Devine DV Clin Lab Haematol; 1992; 14(1):73-9. PubMed ID: 1600696 [No Abstract] [Full Text] [Related]
2. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Vivaldi P; Rossetti G; Galli M; Finazzi G Haematologica; 1997; 82(3):345-7. PubMed ID: 9234588 [TBL] [Abstract][Full Text] [Related]
3. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Lee MT; Nardi MA; Hadzi-Nesic J; Karpatkin M Am J Hematol; 1996 Apr; 51(4):307-14. PubMed ID: 8602632 [TBL] [Abstract][Full Text] [Related]
4. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital. Chng WJ; Sum C; Kuperan P Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828 [TBL] [Abstract][Full Text] [Related]
5. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348 [TBL] [Abstract][Full Text] [Related]
6. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies. Horbach DA; van Oort E; Derksen RH; de Groot PG Thromb Haemost; 1998 Apr; 79(4):790-5. PubMed ID: 9569194 [TBL] [Abstract][Full Text] [Related]
7. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Rauch J; Tannenbaum M; Neville C; Fortin PR Thromb Haemost; 1998 Dec; 80(6):936-41. PubMed ID: 9869164 [TBL] [Abstract][Full Text] [Related]
10. Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies. de Larrañaga G; Forastiero R; Carreras LO; Zala N; Guzman L; Alonso B Thromb Haemost; 1999 Feb; 81(2):317-8. PubMed ID: 10064016 [No Abstract] [Full Text] [Related]
11. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations]. Zerbino DD; Lukasevich LL; Bilynskaia OA Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434 [TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME; Cabiedes J; Reyes E; Cabral AR Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [TBL] [Abstract][Full Text] [Related]
13. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
14. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor]. Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416 [TBL] [Abstract][Full Text] [Related]
15. Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome. Amengual O; Atsumi T; Koike T Clin Immunol; 2004 Aug; 112(2):144-9. PubMed ID: 15240157 [TBL] [Abstract][Full Text] [Related]
16. [Anesthetic management of a patient with antiphospholipid syndrome]. Seima Y; Shiraishi Y; Sakai S; Yokoyama J; Igarashi H; Kimura T Masui; 1998 Feb; 47(2):204-7. PubMed ID: 9513336 [TBL] [Abstract][Full Text] [Related]
18. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time. Angelos MG; Hamilton GC Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249 [TBL] [Abstract][Full Text] [Related]
19. [Physiopathology of the antiphospholipid syndrome]. Said PB; Martinuzzo ME; Carreras LO Sangre (Barc); 1993 Apr; 38(2):131-8. PubMed ID: 8516726 [No Abstract] [Full Text] [Related]
20. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Lackner KJ; von Landenberg C; Barlage S; Schmitz G Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]